SOL Capital Management CO - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
SOL Capital Management CO ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2020$202,000
-13.3%
4,9590.0%0.06%
-3.4%
Q4 2019$233,000
+13.7%
4,959
+3.4%
0.06%
+5.4%
Q3 2019$205,000
+2.0%
4,7980.0%0.06%0.0%
Q1 2019$201,000
-9.5%
4,798
-17.2%
0.06%
-21.1%
Q4 2018$222,000
-11.2%
5,798
-6.8%
0.07%
+6.0%
Q3 2018$250,000
-9.4%
6,223
-9.1%
0.07%
-15.2%
Q2 2018$276,000
+2.6%
6,843
-0.7%
0.08%
+2.6%
Q1 2018$269,000
+6.3%
6,893
-3.5%
0.08%
+6.9%
Q4 2017$253,000
-33.6%
7,143
-24.0%
0.07%
-32.7%
Q3 2017$381,000
-2.8%
9,393
+3.3%
0.11%
-0.9%
Q2 2017$392,000
+1.0%
9,093
-1.1%
0.11%
-1.8%
Q1 2017$388,000
+7.5%
9,193
-1.9%
0.11%
+0.9%
Q4 2016$361,000
-10.6%
9,3720.0%0.11%
-19.3%
Q3 2016$404,000
-1.7%
9,372
-1.1%
0.14%
-1.5%
Q2 2016$411,000
-0.7%
9,472
-7.3%
0.14%
-2.1%
Q1 2016$414,000
-6.1%
10,217
-6.5%
0.14%
-10.3%
Q4 2015$441,000
+5.0%
10,9320.0%0.16%
-3.7%
Q3 2015$420,000
-11.0%
10,932
-3.5%
0.16%
-6.4%
Q2 2015$472,000
-11.8%
11,332
-2.2%
0.17%
-12.2%
Q1 2015$535,000
+4.3%
11,582
-3.5%
0.20%
-1.0%
Q4 2014$513,000
-7.1%
12,0070.0%0.20%
-13.1%
Q3 2014$552,000
-16.5%
12,007
-2.8%
0.23%
-13.3%
Q2 2014$661,000
-1.5%
12,357
-1.6%
0.26%
+0.8%
Q1 2014$671,000
-6.0%
12,557
-6.1%
0.26%
-4.4%
Q4 2013$714,000
+11.0%
13,372
+4.3%
0.27%
+3.0%
Q3 2013$643,000
+2.6%
12,822
+2.1%
0.27%
+4.3%
Q2 2013$627,00012,5570.26%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2023
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,282,289$46,483,4037.25%
Columbia Asset Management 9,960$3610.08%
PARK CIRCLE Co 800$29,0000.03%
PARADIGM ASSET MANAGEMENT CO LLC 1,800$65,2500.02%
Byrne Asset Management LLC 56$2,0000.00%
Retirement Group, LLC 40$1,4500.00%
Bartlett & Co. LLC 240$90.00%
HUNTINGTON NATIONAL BANK 1$400.00%
View complete list of GLAXOSMITHKLINE PLC shareholders